tiprankstipranks
GRI Bio (GRI)
NASDAQ:GRI
US Market

GRI Bio (GRI) Income Statement

Compare
175 Followers

GRI Bio Income Statement

Last quarter (Q3 2024), GRI Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, GRI Bio's net income was $-2.12M. See GRI Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 21.77M$ 0.00$ 0.00$ 100.00K$ 0.00
Gross Profit
$ 21.71M$ -206.00K$ -73.00K$ 100.00K$ -735.00
Operating Expenses
$ 11.33M$ 2.24M$ 1.06M$ 4.81M$ 3.15M
Depreciation and Amortization
$ 57.00K$ 50.00K$ 73.00K$ 75.00K$ 735.00
EBITDA
$ -10.90M$ -2.51M$ -9.21M$ -4.71M$ -3.27M
Operating Income
$ -11.39M$ -2.24M$ -1.06M$ -4.79M$ -3.15M
Other Income/Expenses
$ -1.65M$ -978.00K$ -8.24M$ -34.00K$ -310.07K
Pretax Income
$ -13.04M$ -3.22M$ -1.56M$ -4.82M$ -3.46M
Net Income
$ -13.04M$ -3.54M$ -1.51M$ -4.82M$ -3.46M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -28.25$ -8.43$ -4.65$ -14.87$ -10.68
Diluted EPS
$ -28.25$ -8.43$ -4.65$ -14.87$ -10.68
Weighted Average Shares Outstanding
461.57K 420.00K 324.42K 324.33K 324.33K
Weighted Average Shares Outstanding (Diluted)
461.57K 420.00K 324.42K 324.33K 324.33K
Currency in USD

GRI Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis